Dihexa is a small-molecule angiotensin IV derivative studied for hepatocyte growth factor potentiation and synaptogenesis in preclinical cognitive research models.
Dihexa is an orally stable angiotensin IV-derived research compound developed at Washington State University. It is studied for its capacity to potentiate hepatocyte growth factor (HGF) and its receptor c-Met, a pathway linked to synapse formation, with preclinical work examining synaptogenesis and cognition-related endpoints in animal models.
Research Applications
Handling & Storage
Supplied as a lyophilized powder. Store sealed vials in a cool, dry place away from light; refrigerate after reconstitution and avoid repeated freeze-thaw cycles.
This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
Every batch of Dihexa is independently tested for identity and purity, and ships with its own Certificate of Analysis — lot information included, where a researcher can actually find it.
View Testing Documentation →Batch COA provided with every order.
A curated list of published, peer-reviewed papers indexed in PubMed where Dihexa has been studied. Provided for research context only — linking to the literature does not constitute endorsement of any therapeutic application.
Dihexa is a small-molecule angiotensin IV derivative studied for hepatocyte growth factor potentiation and synaptogenesis in preclinical cognitive research models. This compound is intended for in-vitro research and laboratory use only. Not for human consumption.
Every batch is independently third-party tested using HPLC purity analysis and mass spectrometry. We guarantee ≥99% purity on all our research peptides, with a full Certificate of Analysis provided for each lot.
Orders placed before 4PM Pacific Time ship same-day, Monday–Friday. You'll receive a tracking number via email once your order leaves our facility. All orders are shipped with discreet packaging.
